Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.45 Billion CNY | 9.75% |
| 2022 | 2.16 Billion CNY | -19.73% |
| 2021 | 2.69 Billion CNY | 16.86% |
| 2020 | 2.3 Billion CNY | 12.07% |
| 2019 | 2.05 Billion CNY | 5.53% |
| 2018 | 1.94 Billion CNY | 2.47% |
| 2017 | 1.9 Billion CNY | 22.75% |
| 2016 | 1.54 Billion CNY | 23.25% |
| 2015 | 1.25 Billion CNY | 25.73% |
| 2014 | 999.29 Million CNY | 22.04% |
| 2013 | 818.82 Million CNY | 29.11% |
| 2012 | 634.23 Million CNY | 29.67% |
| 2011 | 489.1 Million CNY | 24.03% |
| 2010 | 394.34 Million CNY | 19.98% |
| 2009 | 328.67 Million CNY | 13.77% |
| 2008 | 288.88 Million CNY | 26.81% |
| 2007 | 227.81 Million CNY | 23.84% |
| 2006 | 183.95 Million CNY | 33.9% |
| 2005 | 137.38 Million CNY | -1.41% |
| 2004 | 139.34 Million CNY | -5.57% |
| 2003 | 147.56 Million CNY | 3.61% |
| 2002 | 142.42 Million CNY | 59.84% |
| 2001 | 89.1 Million CNY | -7.0% |
| 2000 | 95.81 Million CNY | -31.53% |
| 1999 | 139.93 Million CNY | -12.08% |
| 1998 | 159.16 Million CNY | 7.48% |
| 1997 | 148.08 Million CNY | -8.01% |
| 1996 | 160.98 Million CNY | -1.06% |
| 1995 | 162.7 Million CNY | 23.31% |
| 1994 | 131.95 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 538.25 Million CNY | 1089.92% |
| 2024 Q1 | 461.66 Million CNY | -41.66% |
| 2024 Q2 | 45.23 Million CNY | -90.2% |
| 2023 Q3 | 588.59 Million CNY | 8.36% |
| 2023 Q2 | 543.17 Million CNY | 5.2% |
| 2023 Q4 | 791.32 Million CNY | 34.44% |
| 2023 FY | 2.37 Billion CNY | 9.75% |
| 2023 Q1 | 516.3 Million CNY | 0.71% |
| 2022 Q1 | 737 Million CNY | 11.24% |
| 2022 Q3 | 567.61 Million CNY | 65.17% |
| 2022 Q4 | 512.67 Million CNY | -9.68% |
| 2022 Q2 | 343.64 Million CNY | -53.37% |
| 2022 FY | 2.16 Billion CNY | -19.73% |
| 2021 Q1 | 684.4 Million CNY | 18.14% |
| 2021 Q2 | 686.65 Million CNY | 0.33% |
| 2021 Q3 | 658.64 Million CNY | -4.08% |
| 2021 Q4 | 662.53 Million CNY | 0.59% |
| 2021 FY | 2.69 Billion CNY | 16.86% |
| 2020 Q4 | 579.3 Million CNY | 3.69% |
| 2020 Q2 | 594.55 Million CNY | 4.09% |
| 2020 Q1 | 571.22 Million CNY | 10.32% |
| 2020 FY | 2.3 Billion CNY | 12.07% |
| 2020 Q3 | 558.7 Million CNY | -6.03% |
| 2019 Q4 | 517.78 Million CNY | 11.79% |
| 2019 FY | 2.05 Billion CNY | 5.53% |
| 2019 Q3 | 463.17 Million CNY | -14.04% |
| 2019 Q1 | 535.87 Million CNY | 6.6% |
| 2019 Q2 | 538.79 Million CNY | 0.55% |
| 2018 Q3 | 366.13 Million CNY | -33.79% |
| 2018 FY | 1.94 Billion CNY | 2.47% |
| 2018 Q4 | 502.69 Million CNY | 37.3% |
| 2018 Q1 | 526.09 Million CNY | 4.03% |
| 2018 Q2 | 552.97 Million CNY | 5.11% |
| 2017 Q4 | 505.73 Million CNY | -0.4% |
| 2017 Q2 | 458.85 Million CNY | 7.08% |
| 2017 FY | 1.9 Billion CNY | 22.75% |
| 2017 Q1 | 428.53 Million CNY | -0.99% |
| 2017 Q3 | 507.74 Million CNY | 10.66% |
| 2016 Q3 | 428.52 Million CNY | 27.8% |
| 2016 Q1 | 351.9 Million CNY | 3.33% |
| 2016 FY | 1.54 Billion CNY | 23.25% |
| 2016 Q4 | 432.81 Million CNY | 1.0% |
| 2016 Q2 | 335.29 Million CNY | -4.72% |
| 2015 FY | 1.25 Billion CNY | 25.73% |
| 2015 Q4 | 340.55 Million CNY | -0.7% |
| 2015 Q3 | 342.95 Million CNY | 22.13% |
| 2015 Q2 | 280.81 Million CNY | -3.85% |
| 2015 Q1 | 292.05 Million CNY | 1.2% |
| 2014 Q4 | 288.59 Million CNY | 13.08% |
| 2014 FY | 999.29 Million CNY | 22.04% |
| 2014 Q1 | 222.15 Million CNY | -6.02% |
| 2014 Q2 | 233.32 Million CNY | 5.03% |
| 2014 Q3 | 255.21 Million CNY | 9.38% |
| 2013 Q2 | 182.41 Million CNY | -3.14% |
| 2013 Q3 | 211.68 Million CNY | 16.04% |
| 2013 FY | 818.82 Million CNY | 29.11% |
| 2013 Q4 | 236.39 Million CNY | 11.68% |
| 2013 Q1 | 188.32 Million CNY | 7.01% |
| 2012 Q2 | 142.35 Million CNY | -0.59% |
| 2012 Q3 | 172.7 Million CNY | 21.33% |
| 2012 Q4 | 175.98 Million CNY | 1.9% |
| 2012 FY | 634.23 Million CNY | 29.67% |
| 2012 Q1 | 143.18 Million CNY | 8.19% |
| 2011 Q4 | 132.34 Million CNY | -5.65% |
| 2011 Q1 | 106.37 Million CNY | -6.51% |
| 2011 Q2 | 110.11 Million CNY | 3.51% |
| 2011 Q3 | 140.26 Million CNY | 27.39% |
| 2011 FY | 489.1 Million CNY | 24.03% |
| 2010 Q4 | 113.78 Million CNY | 4.58% |
| 2010 Q2 | 89.82 Million CNY | 9.65% |
| 2010 FY | 394.34 Million CNY | 19.98% |
| 2010 Q1 | 81.92 Million CNY | -10.96% |
| 2010 Q3 | 108.8 Million CNY | 21.13% |
| 2009 Q4 | 92.01 Million CNY | 14.64% |
| 2009 Q2 | 78.75 Million CNY | 1.43% |
| 2009 Q1 | 77.64 Million CNY | -7.57% |
| 2009 FY | 328.67 Million CNY | 13.77% |
| 2009 Q3 | 80.26 Million CNY | 1.91% |
| 2008 FY | 288.88 Million CNY | 26.81% |
| 2008 Q4 | 84 Million CNY | 19.7% |
| 2008 Q3 | 70.18 Million CNY | -8.18% |
| 2008 Q1 | 58.26 Million CNY | -22.86% |
| 2008 Q2 | 76.43 Million CNY | 31.19% |
| 2007 Q2 | 43.57 Million CNY | -13.84% |
| 2007 Q3 | 58.13 Million CNY | 33.43% |
| 2007 FY | 227.81 Million CNY | 23.84% |
| 2007 Q4 | 75.53 Million CNY | 29.92% |
| 2007 Q1 | 50.57 Million CNY | -4.7% |
| 2006 Q4 | 53.06 Million CNY | 11.9% |
| 2006 Q1 | 30.36 Million CNY | -34.69% |
| 2006 Q3 | 47.42 Million CNY | -10.7% |
| 2006 FY | 183.95 Million CNY | 33.9% |
| 2006 Q2 | 53.1 Million CNY | 74.91% |
| 2005 Q2 | 35.58 Million CNY | 53.92% |
| 2005 Q1 | 23.12 Million CNY | -55.59% |
| 2005 Q3 | 32.19 Million CNY | -9.54% |
| 2005 Q4 | 46.48 Million CNY | 44.41% |
| 2005 FY | 137.38 Million CNY | -1.41% |
| 2004 Q2 | 29.47 Million CNY | -0.01% |
| 2004 FY | 139.34 Million CNY | -5.57% |
| 2004 Q4 | 52.06 Million CNY | 83.75% |
| 2004 Q3 | 28.33 Million CNY | -3.85% |
| 2004 Q1 | 29.47 Million CNY | -35.06% |
| 2003 Q2 | 38.47 Million CNY | 34.53% |
| 2003 Q3 | 35.1 Million CNY | -8.76% |
| 2003 Q4 | 45.38 Million CNY | 29.28% |
| 2003 FY | 147.56 Million CNY | 3.61% |
| 2003 Q1 | 28.6 Million CNY | -40.51% |
| 2002 Q4 | 48.07 Million CNY | 32.17% |
| 2002 Q3 | 36.37 Million CNY | 55.97% |
| 2002 Q1 | 35.04 Million CNY | 0.0% |
| 2002 FY | 142.42 Million CNY | 59.84% |
| 2002 Q2 | 23.32 Million CNY | -33.45% |
| 2001 FY | 89.1 Million CNY | -7.0% |
| 2000 FY | 95.81 Million CNY | -31.53% |
| 1999 FY | 139.93 Million CNY | -12.08% |
| 1998 FY | 159.16 Million CNY | 7.48% |
| 1997 FY | 148.08 Million CNY | -8.01% |
| 1996 FY | 160.98 Million CNY | -1.06% |
| 1995 FY | 162.7 Million CNY | 23.31% |
| 1994 FY | 131.95 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 19.29 Billion CNY | 87.279% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 4.59 Billion CNY | 46.634% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.89 Billion CNY | 37.024% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.13 Billion CNY | -115.517% |
| Aurora Optoelectronics Co.,Ltd. | -319.56 Million CNY | 868.028% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 23.41 Million CNY | -10382.884% |
| NanJing Pharmaceutical Company Limited | 3.31 Billion CNY | 25.924% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 936.59 Million CNY | -162.051% |